About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
PitpnaGt(OST1152)Lex
gene trap OST1152, Lexicon Genetics
MGI:2676301
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex involves: 129S5/SvEvBrd MGI:2676371


Genotype
MGI:2676371
hm1
Allelic
Composition
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
Genetic
Background
involves: 129S5/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
PitpnaGt(OST1152)Lex mutation (0 available); any Pitpna mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 40% died within 48 hours of birth
• neonatal death putatively a result of the cessation of nutrients provided by maternal circulation
• all but 1 mouse died by 11 days of age
• early postnatal death putatively a result of the cessation of nutrients provided by maternal circulation

adipose tissue
• absence of axillary fat pads
• absence of inguinal fat pads

behavior/neurological
• coarse action tremors upon limb extension
• by 4 days of age all mice were severely ataxic and unable to maintain themselves upright
• approximately 10% of mice exhibited spontaneous seizures

cellular
• increased apoptosis in the cerebellum, particularly in the external granule layer

digestive/alimentary system
• intestinal microvesicular steatosis similar to that observed in human chylomicron retention disease
• intestinal cells were larger than those of wild-type due to an accumulation of diet-derived lipids

endocrine/exocrine glands
• aberrant morphology of observed islets
• greater than 2-fold decrease in the absolute islet number relative to controls

growth/size/body
• by 10 days of age, surviving mice were 2.5 fold less massive than wild-type and heterozygous littermates

homeostasis/metabolism
• modest elevations consistent with the amount of hepatic stress
• 9-fold reduction in serum glucose levels relative to controls, accompanied by increased levels of gluconeogenic compounds
• 9-fold reduction in serum insulin levels relative to controls
• modest elevations consistent with the amount of hepatic stress
• kinetic defects in the rate of glycogenolysis
• 10-fold decrease in vitamin E in the brain

liver/biliary system
• aponecrosis of hepatocytes
• intracellular accumulation of neutral lipid and free fatty acid mass, resulting in microvesicular steatosis

nervous system
• approximately 10% of mice exhibited spontaneous seizures
• degeneration indicated by reactive gliosis
• infiltration by inflammatory cells in the dorsal spinal column
• aponecrosis of motor neuron cell bodies in the ventral horn
• white matter was thin and sparse in regions of the cervical, lumbar, and thoracic spinal cord
• aponecrotic spinocerebellar disease characterized by reactive gliosis of the cerebellum and brainstem
• also affecting the white and gray matter of the spinal cord
• observed in both white and gray matter, particularly in the dorsal spinal column

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
chylomicron retention disease DOID:0060357 OMIM:246700
J:85204





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory